
Product Usage: This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals. It is not approved for human or animal consumption. Misuse, misbranding, or mislabeling as a drug, food, or cosmetic is strictly prohibited. All information provided is for educational purposes only.
PT-141
£49.99
In stock
PT-141, scientifically known as bremelanotide, is a synthetic peptide and melanocortin receptor agonist under investigation for its potential to address sexual dysfunction. It uniquely influences sexual arousal through central nervous system pathways rather than focusing on vascular mechanisms, distinguishing it from other treatments such as PDE5 inhibitors. PT-141 has gained approval for the management of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, demonstrating its clinical relevance. Requires reconstitution before use.
Loading stock...
Size:
10 mg
Ships tomorrow morning if ordered by 2PM UTC
Free international delivery within 1-3 business days on orders over £250, with a tracking number provided.
Third party tested
FREE Bacteriostatic Water
For every £75 you spend, get 1 FREE bottle of Bacteriostatic Water to reconstitute your peptides.


PT-141
£49.99
In stock
Buy 3+ for £50 each and save 5%
Buy 5+ for £50 each and save 8%
Buy 10+ for £50 each and save 10%
Loading stock...
Size:
10 mg
Ships tomorrow morning if ordered by 2PM UTC
Free international delivery within 1-3 business days on orders over £250, with a tracking number provided.
Third party tested
FREE Bacteriostatic Water
For every £75 you spend, get 1 FREE bottle of Bacteriostatic Water to reconstitute your peptides.
PT-141, scientifically known as bremelanotide, is a synthetic peptide and melanocortin receptor agonist under investigation for its potential to address sexual dysfunction. It uniquely influences sexual arousal through central nervous system pathways rather than focusing on vascular mechanisms, distinguishing it from other treatments such as PDE5 inhibitors. PT-141 has gained approval for the management of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, demonstrating its clinical relevance. Requires reconstitution before use.
Product Usage: This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals. It is not approved for human or animal consumption. Misuse, misbranding, or mislabeling as a drug, food, or cosmetic is strictly prohibited. All information provided is for educational purposes only.
Characteristics
Molecular Formula
C225H348N60O68
CAS Number
2023788-19-2
Molar Mass
5047.61g/mol
Amino Acid
Sequence
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
Synonyms
LY3298176
Solubility
Water-soluble |
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder - requires reconstitution
How does PT-141 work?
PT-141 primarily acts as a melanocortin receptor agonist, with highest affinity for the melanocortin 4 receptor (MC4R) and melanocortin 1 receptor (MC1R). Research suggests the following mechanisms: 1. Central Nervous System: PT-141 activates MC4R in specific brain regions, particularly the hypothalamus and brainstem areas involved in sexual response. This activation is thought to influence neural pathways related to sexual desire and arousal. 2. Neurotransmitter Modulation: Studies indicate that PT-141 may increase dopamine release in the medial preoptic area, a region crucial for sexual motivation. 3. Peripheral Effects: PT-141's interaction with MC1R on melanocytes has been studied for potential effects on skin pigmentation.
Research
1. HSDD in Premenopausal Women:
Multiple Phase III clinical trials have evaluated PT-141's efficacy for HSDD.
Studies typically measured changes in sexual desire and related distress using validated scales like the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Desire/Arousal/Orgasm (FSDS-DAO).
Research has examined various dosing regimens and administration methods.
2. Other Areas of Investigation:
Male Sexual Function: Some studies have explored potential effects on erectile function, though this is not an FDA-approved use.
Dermatology: Limited research has investigated PT-141's influence on melanogenesis and potential applications in pigmentation disorders.
Cardiovascular Effects: Studies have examined PT-141's impact on blood pressure and heart rate, primarily for safety monitoring.
Side Effects
Nausea
Flushing
Headache
Focal hyperpigmentation, which is generally reversible upon discontinuation of the drug
Summary
PT-141 (Bremelanotide) is a synthetic peptide that has been the subject of extensive clinical research, particularly in the field of female sexual health. It is approved use for HSDD in premenopausal women represents a significant development in this therapeutic area. Ongoing studies continue to explore its mechanisms of action, potential applications, and long-term safety profile.
Characteristics
Molecular Formula
C225H348N60O68
CAS Number
2023788-19-2
Molar Mass
5047.61g/mol
Amino Acid
Sequence
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
Synonyms
LY3298176
Solubility
Water-soluble |
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder - requires reconstitution
How does PT-141 work?
PT-141 primarily acts as a melanocortin receptor agonist, with highest affinity for the melanocortin 4 receptor (MC4R) and melanocortin 1 receptor (MC1R). Research suggests the following mechanisms: 1. Central Nervous System: PT-141 activates MC4R in specific brain regions, particularly the hypothalamus and brainstem areas involved in sexual response. This activation is thought to influence neural pathways related to sexual desire and arousal. 2. Neurotransmitter Modulation: Studies indicate that PT-141 may increase dopamine release in the medial preoptic area, a region crucial for sexual motivation. 3. Peripheral Effects: PT-141's interaction with MC1R on melanocytes has been studied for potential effects on skin pigmentation.
Research
1. HSDD in Premenopausal Women:
Multiple Phase III clinical trials have evaluated PT-141's efficacy for HSDD.
Studies typically measured changes in sexual desire and related distress using validated scales like the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Desire/Arousal/Orgasm (FSDS-DAO).
Research has examined various dosing regimens and administration methods.
2. Other Areas of Investigation:
Male Sexual Function: Some studies have explored potential effects on erectile function, though this is not an FDA-approved use.
Dermatology: Limited research has investigated PT-141's influence on melanogenesis and potential applications in pigmentation disorders.
Cardiovascular Effects: Studies have examined PT-141's impact on blood pressure and heart rate, primarily for safety monitoring.
Side Effects
Nausea
Flushing
Headache
Focal hyperpigmentation, which is generally reversible upon discontinuation of the drug
Summary
PT-141 (Bremelanotide) is a synthetic peptide that has been the subject of extensive clinical research, particularly in the field of female sexual health. It is approved use for HSDD in premenopausal women represents a significant development in this therapeutic area. Ongoing studies continue to explore its mechanisms of action, potential applications, and long-term safety profile.
Subscribe to our newsletter
Receive weekly updates with the newest insights, trends, and tools, straight to your email.

PEPTIDE
SUPPLIED
Contact Us
Email:
support@peptidesupplied.com
Peptides
Company
All products on this site are intended for research and development purposes only and are not meant for human consumption of any kind. Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
© 2025, Peptide Supplied™. All Rights Reserved.
Subscribe to our newsletter
Receive weekly updates with the newest insights, trends, and tools, straight to your email.

PEPTIDE
SUPPLIED
Contact Us
Email:
support@peptidesupplied.com
Peptides
Anti-Aging
Anti-Inflammatory
Cardiovascular Health
Endocrinology
Energy Support
Immunomodulator
Longevity
Metabolic Regulation
Nootropic
Reproductive Health
Sleep/Circadian Rhythm
Tissue Repair & Regeneration
Weight Management
Company
All products on this site are intended for research and development purposes only and are not meant for human consumption of any kind. Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
© 2025, Peptide Supplied™. All Rights Reserved.